nanoCAR-T mRNA Service


Catalog Number Pack Size List Price* Quantity
nanoCAR-T Inquire   Inquire

* CHF, excl. 8.1% VAT and shipping costs


Product Description

nanoCAR-T mRNA service, designed to enhance CAR-T therapy with non-viral mRNA technology.
Unlike traditional viral-based CAR-T approaches, this service utilizes mRNA encapsulated in lipid nanoparticles, enabling temporary yet potent CAR expression with minimized side effects. Abnova’s proprietary NanoAb™ VHH antibodies also enhance targeting precision, providing improved tissue penetration in complex tumor environments.
This flexible, scalable, and cost-effective solution is ideal for applications in cancer and autoimmune disease research.

Category Custom Service
Supplier Abnova
Regulatory Status RUO
Research Field Cancer, Autoimmune disease
Tech. Data Sheet View datasheet
Link To Supplier https://www.abnova.com
Material Safety Data Sheet Download PDF